Explore the CMS proposal's impact on drug pricing negotiations, innovation, and pharmaceutical investment strategies in this crucial healthcare policy update.

Explore the evolving landscape of cancer care costs and insurance regulations, revealing financial challenges in treatment access and the role of federal policies.

Explore how the Advisory Board supports healthcare leaders with insights and strategies on industry trends, FDA approvals, AI, and health equity shaping the U.S. insurance and healthcare sectors.